Clinical trials

  • Cabozantinib for Hepatocellular carcinoma
  • ES2B-C001 for HER2-positive breast cancer|Metastatic breast cancer|Locally advanced unresectable breast cancer
  • [AL[18F]F]FAPI-74 for Fever of unknown origin (FUO) | Inflammation of unknown origin (IUO) | IgG4-related disease | Axial spondyloarthritis
  • KIN-2787 for BRAF and/or NRAS mutation-positive solid tumours
  • Acetylsalicylic acid for Pregnancy-associated hypertension | Pre-eclampsia | Fetal growth restriction
  • OSIMERTINIB for Non-small cell lung cancer
  • AVELUMAB for Metastatic urothelial cancer | Locally advanced urothelial cancer
  • SARGRAMOSTIM for Ovarian cancer
  • AMOXICILLIN SODIUM for Systemic infections
  • TRANEXAMIC ACID for Slipped capital femoral epiphysis (SCFE) | Legg-Calvé-Perthes Disease (LCPD) | Neuromuscular conditions | Secondary hip dysplasia | Developmental dysplasia of the hip (DDH)
  • WAL0623 for Glomerular kidney disease with proteinuria|IgA nephropathy|Membranous nephropathy|Glomerulonephritis|Focal segmental glomerulosclerosis|Alport syndrome
  • Decitabine; Cedazuridine for Acute myeloid leukaemia | Myelodysplastic syndrome | Chronic myelomonocytic leukaemia | Solid tumor